# DAOIB for the Treatment of Brain Fog

> **NCT05764538** · PHASE2 · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Long COVID

## Interventions

- **DRUG:** DAOIB

## Key facts

- **NCT ID:** NCT05764538
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-27
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05764538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05764538, "DAOIB for the Treatment of Brain Fog". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05764538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*